Compare BIO-TECHNE Corp (TECH) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Warner Music Group Corp — how do they compare? BIO-TECHNE Corp trades at $72.13 (market cap $11.24B), while Warner Music Group Corp trades at $25.06 (market cap $13.82B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals.
| TECH | WMG | |
|---|---|---|
Market Cap | $11.24B | $13.82B |
Sector | Health | Media |
52-Week High | $72.29 | $34.72 |
52-Week Low | $43.31 | $23.65 |
Enterprise Value | $11.32B | $18.12B |
Dividend Yield | 0.44% | 3.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Warner Music Group (WMG) trades at $26.39, showing modest daily movement with a slight 0.19% decline. The stock exhibits bearish technical signals despite recent earnings beats in Q1 and Q2 2026. Fundamentally, revenue has grown consistently from $5.9B in 2022 to $6.7B in 2025, though net income margin declined to 5.44%. The company maintains strong profitability metrics with 45.77% gross margin and 25.38% ROE, while analyst sentiment remains positive with 66.7% buy ratings.
WMG presents a compelling value opportunity with reasonable valuation multiples (P/E 21.11, P/S 1.89) and strong analyst support. Near-term catalysts include streaming revenue growth and new licensing partnerships, though risks include margin pressure and leadership transitions. The stock's current technical weakness may offer entry points for long-term investors seeking exposure to music industry consolidation and digital transformation trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
